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-Background: Since the past 2 decades, new evidence for brain pla
ticity has caused a shift in both preclinical and clinical ECT researc
from falsifying the “brain damage hypothesis” toward exploring ECT
enabling brain (neuro)plasticity effects.
Methods: By reviewing the available animal and human literature, w
examined the theory that seizure-induced structural changes are cruci
for the therapeutic efficacy of ECT.
Results: Both animal and human studies suggest electroconvulsiv
stimulation/electroconvulsive therapy (ECT)-related neuroplasticity (neu
rogenesis, synaptogenesis, angiogenesis, or gliogenesis).
Conclusion: It remains unclear whether structural changes might ex
plain the therapeutic efficacy and/or be related to the (transient) learnin
and memory impairment after ECT. Methods to assess in vivo brain pla
ticity of patients treated with ECT will be of particular importance fo
future longitudinal studies to give support to the currently available corr
lational data.
Key Words: electroconvulsive therapy, neuroplasticity, neurogenesis,
angiogenesis, synaptogenesis, gliogenesis, hippocampus, BDNF,
magnetic resonance imaging
(J ECT 2014;00: 00–00)
Concerned professionals and critics of electroconvulsivtherapy (ECT) have argued that ECT is causing brain dam
age.1–4 Since the past 2 decades, new evidence for brain plas
ticity5 has caused a shift in both preclinical and clinical EC
research from falsifying the “brain damage hypothesis”6–10 to
ward exploring ECT’s enabling brain (neuro)plasticity effect
Neuroplasticity refers to the brain’s ability to reorganize i
self. This is achieved by synaptic structural remodeling throug
the formation, organization, and maintenance of neurite com
ponents of synapses (synaptogenesis) as well as by the genera
tion of new neurons (neurogenesis)11 in the subventricula
zone12 and the subgranular layer of the dentate gyrus in the hip
pocampus.13 Although there is limited cortical synaptogenes
and slower turnover of new hippocampal neurons beyond ado
lescence, these are nevertheless, stimulated by antidepressan
therapy and hampered in depressive states.11 Stress reduce
adult hippocampal neurogenesis,14,15 produces dendritic atro
phy,16 and leads to decreased hippocampal volume,17 possibl
secondary to a dysregulation of the hypothalamic-pituitary
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Copyright © Lippincott Williams & Wilkins. Unauhas also been reported to reduce hippocampal volume.
Hypothalamic-pituitary-adrenal feedback dysregulation migh
be explained by marked changes in the function of the amygdal
(increased), hippocampus (decreased), and the prefrontal corte
(decreased).11,23
According to the neurotrophin hypothesis,5,24 aberran
neurogenesis is caused by a (stress-induced) lower expressio
of brain-derived neurotrophic factor (BDNF), but antidepressan
therapy restores most aspects of this HPA dysregulation.11 Ce
proliferation and increase in newborn neurons increases hippo
campal inhibitory control over the HPA-axis activity afte
stress.25–27 Although there is strong evidence from preclinica
and clinical studies to support a neurotrophin hypothesis of de
pression, there are also limitations, the main caveat being tha
decreased neurogenesis does not always induce depressiv
behaviors.28–30 Low serum levels of BDNF are a state abnorma
ity that is evident during depression and normalizes during re
mission in patients treated with antidepressant.31–34 Howeve
a recent meta-analysis showed that low BDNF levels in de
pressed patients are probably less robust, possibly due to a larg
amount of unexplained between-study heterogeneity in ou
comes, underpowered study designs, and publication bias of pre
vious meta-analyses.34 Increases in serum levels of BDN
during antidepressant treatment seem to be confined to som
antidepressants and do not parallel clinical characteristics, suc
as the severity of depressive symptoms.31
Research has been particularly focused on the questio
whether stress-induced changes in structures like hippocampu
amygdala, and prefrontal cortex can be reversed by antide
pressive therapies, such as electroconvulsive stimulation (ECS
an animal model for ECT) and ECT, and whether this corre
lates with clinical improvement. Here, we present a review o
the literature examining the combined anatomical-ictal theory,3
enouncing that seizure-induced effects in the limbic system ar
crucial for the therapeutic efficacy of ECT.n
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We conducted a PubMed literature search from the inceptio
of the database until December 2013 using the following searc
terms: ECT combined with (All Fields and MeSH Terms) neuro
nal plasticity or neurogenesis or angiogenesis or synaptogenes
or gliogenesis or hippocampus or magnetic resonance imagin
(MRI) or BDNF or magnetic resonance spectroscopy.
Our search included all research papers from a neuroplas
ticity perspective along the search strategy aforementioned o
depression and depression models in rodents, nonhuman pr
mates and humans. Data published as posters were not included
As the detection of neurogenesis requires evidence that cell d
vision has taken place and that the proliferating cells different
ate and mature into neurons,36 papers were included whe
based on this evidence. As BDNF surpasses all other neuro
trophins in its role in regulating synaptic plasticity, we focuse
on this neurotrophin. We excluded papers on magnetic seizur
therapy and transcranial magnetic stimulation, papers describinwww.ectjournal.com 1
thorized reproduction of this article is prohibited.
TABLE 1. Selected Publications Showing the Effect of ECS on Neurogenesis and Synaptogenesis
Author, Year Species/N
Used Technique to Assess Sprouting
and Cell Proliferation Summary of Findings
Jorgensen and
Bolwig, 1979
Rats Quantitative immunoelectrophoresis
of rat brain synaptic proteins
ECS results in synaptic proteins,
suggesting hippocampal synaptogenesis;
sustained increase in the neuronal cell
adhesion molecule (N-CAM),
which is involved in synaptogenesis
N=30
Bolwig et al, 1980 Rats Crossed immunoelectrophoresis ECS results in synaptic proteins,
suggesting hippocampal synaptogenesisN=36
Vaidya et al, 1999 Mice Timm staining, cell counting,
and Nadler silver staining
Repeated (5–10 daily treatments),
but not a single ECS significantly
increases hippocampal granule cell;
sprouting (maximum at 12 days
after last ECS). Effect still observed up to
6 months after the last ECS.
Increased expression of brain-derived
neurotrophic factor is necessary
but not sufficient for the induction
on this sprouting.
N=29
Rats
N=16
Madhav et al, 2000 Rats 5-HT immunocytochemistry Repeated ECS (5 ECSs over 10 days)
promotes mossy fiber sprouting
and the sprouting of serotonergic
axons in the lesioned rat hippocampus.
N=8
(4 sham and 4 ECS)
Madsen et al, 2000 Rats BrdU followed by double staining
with a neuron-specific marker
A single ECS significantly increased the
number of newborn cells in the
dentate gyrus, which survived for
at least 3 months. A series of seizures
further increased neurogenesis,
indicating a dose-dependent mechanism.
N=63
Malberg et al, 2000 Rats BrdU BrdU-positive cells significantly increased
in the animals treated with chronic ECS,
suggesting ECS increases neurogenesis.
N=32
Scott et al, 2000 Rats BrdU and NeuN quantification One month after 8 ECS seizures, ECS-treated rats
had approximately twice as many BrdU-positive
cells as sham-treated controls in the dentate gyrus.
N=13
(6 sham; 7 ECS)
Hellsten et al, 2002 Rats BrdU and NeuN ECS can increase hippocampal neurogenesis
even in the presence of elevated levels of
glucocorticoids, known to suppress
hippocampal neurogenesis.
N=36
Segi-Nishida et al, 2008 Rats BrdU and triple immunostaining
to characterize the phenotype
of BrdU-labeled cells
At an early mitotic phase, ECS increases the
proliferation of quiescent progenitors and
then at a later phase increases the proliferation
of amplifying progenitors in the subgranular
zone of the dentate gyrus.
N=12
(6 sham; 6 ECS)
Chen et al, 2009 Rats BrdU Neurogenesis, synaptogenesis, and remodeling
of synapses were demonstrated; a highly
significant increase in the number of
synapses and an increased synaptic density
in the CA1 area of the hippocampus in rats
given repeated ECS were shown.
N=20
(9 sham; 11 ECS)
Ito et al, 2010 Rats BrdU Application of a single ECS and 10 ECSs
increased cell proliferation in the SGZ,
whereas 20 ECSs did not produce a difference
in cell proliferation compared to the sham
group. Ten times ECS induced a significant
increase in cell proliferation by 1.3-fold
compared to a single ECS group.
N=24
Zhao et al, 2012 Rats Hippocampal injection
of the GFP retrovirus
Administration of ECS promotes the maturation
of dendritic spines in newborn cells and
increases spine density in mature cells,
suggesting that newborn granule cells form
stronger synaptic connections within
the dentate circuitry.
N=12
(Continued next page)
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TABLE 1. (Continued)
Author, Year Species/N
Used Technique to Assess Sprouting
and Cell Proliferation Summary of Findings
Nakamura et al, 2013 Rats BrdU, NeuN, S-100b The amount of cell proliferation in the
hippocampus 3 days after a series of
10 repeated ECS sessions increased twice
as much as the sham-treated group.
N=12
Weber et al, 2013 Mice Transgenic fate mapping;
type 1 cells and their progeny
are selectively labeled with
the reporter protein b-galactosidase
ECS exerts (over 3 months) a powerful
proneurogenic effect in the dentate gyrus
by stimulating asymmetric proliferation
of type 1 cells, the progeny of which
develops into granule neurons.
5 ECS and 5 sham
groups.
N = 3–8 per group.
BrdU, bromodeoxyuridine, a thymidine analog that labels dividing cells in S-phase, is a marker of dividing cells; NeuN is a cell-specific biomarker;
S-100b is a glial cell marker ; GFP retrovirus, green fluorescent protein retrovirus, was used to label newborn granule cells and to examine whether their
integration is regulated by ECS.
Journal of ECT • Volume 00, Number 00, Month 2014 Brain Enabling Effects of ECTgenetic expressions after ECS/ECT, and papers examining th
neurophysiology and underlying signaling and binding mecha
nisms or pathways, as these were beyond the scope of this re
view. References of all relevant articles were screened fo
additional papers.
RESULTS
We included 11 articles on neuroplasticity, 24 on neurogen
esis, 6 on angiogenesis, 3 on synaptogenesis, 5 on gliogenesi
10 on MRI and hippocampal changes, 25 on BDNF (of whic
11 were in humans), 6 on magnetic resonance spectroscopy.
Twenty-seven studies (some of which overlap across cate
gories) have examined neurogenesis, synaptogenesis, angiogen
esis, or gliogenesis of ECS in animals (rodents, n = 25; an
nonhuman primates, n = 2). Neuroplasticity effects of ECT i
humans were described in 4 recent MRI studies, with a total o
37 subjects.
Neuroplasticity of ECS in Animals
Chronic administration of antidepressants increases BDN
expression in the hippocampus of animal models.37,38 Electro
convulsive stimulation in animals has also shown an increas
in serum BDNF,39–41 although this has not always been con
firmed.42 Up-regulation of BDNF expression suggests a rol
for synaptic plasticity and alterations of neuronal structure i
the actions of long-term ECS.43 Expression of BDNF predom
nantly occurs in hippocampus, prefrontal cortex area, striatum
and occipital cortex,39,40 although some authors report differen
results.38,44 Consistent with the effect of ECS on growth factor
preclinical studies have shown that ECS leads to increase
neurogenesis, synaptogenesis, angiogenesis, and glial prolifera
tion in the hippocampus. Only recently, the first evidence tha
ECS is changing neuroplasticity outside the hippocampu
(frontal brain area,45 amygdala46,47) was published. Tables 1 to 3 giv
an overviewof selected publications showing the effect of ECS o
neurogenesis and synaptogenesis,7,48–59 angiogenesis,60–66 an
gliogenesis.67–73
Neuroplasticity of ECS in Nonhuman Primates
Perera et al8 have shown in 6 adultMacaca radiatamonkey
that ECS robustly increased precursor cell proliferation in th
subgranular zone of the dentate gyrus. Most of these precu
sors differentiated into neurons or endothelial cells, whereas
few matured into glial cells. The ECS interventions were no© 2014 Lippincott Williams & Wilkins
Copyright © Lippincott Williams & Wilkins. Unauaccompanied by increased hippocampal cell death or injury
which was confirmed by another nonhuman primate stud
(8 Macaca mulatta monkeys) showing no change in the num
ber of neurons or glia in the hippocampal pyramidal cell laye
(CA1-CA3) and frontal cortex, likely areas for neuronal damage.1
Neuroplasticity of ECT in Humans
BDNF and ECT
Brain-derived neurotrophic factor surpasses all othe
neurotrophins in its role in regulating synaptic plasticity and ha
been investigated in ECT by several research groups. Table
shows the conflicting associations between changes in serum o
plasma BDNF levels and the clinical improvements after ECT i
patients with treatment-resistant depression.74–84
Structural Imaging
Differing results have been reported as to the effect of EC
on brain structure. Few studies have compared structural brai
imaging (computed tomography and MRI) findings before an
after an ECT course. Studies conducted at a single time afte
ECT (and thus suffering from severe methodological problems
showed a temporary increase of T1 relaxation85,86 or T2 relaxa
tion87 time, suggesting temporary breakdown of the blood-brai
barrier during ECT. None of the MRI studies85,88–92 coul
provide evidence of persistent structural changes after a cours
of ECT. Kunigiri et al93 showed no increase in T2 relaxation tim
(corresponding to water content) in the hippocampus after ECT
suggesting that hippocampal edema does not result from ECT.
Nordanskog et al94,95 investigated 12 patients with depres
sion and ongoing antidepressive pharmacological treatment wit
clinical ratings and 3-T magnetic resonance imaging withi
1 week before and after the ECT series in a prospective stud
They found a significant volume increase in the left hippocam
pus as well as in the right hippocampus after ECT (mean volum
increase of right hippocampus, 4.3%; and mean volume increas
of left hippocampus, 5.1%). There was no evidence of edem
in the hippocampus on T2-weighted fluid-attenuated inve
sion recovery images.94 However, in a follow-up study afte
6 months,95 this volume increase returned to baseline. Th
authors concluded that the immediate increase in hippocampa
volume after ECT was reversible and not related to clinical o
cognitive outcome and suggested that the volume decrease coul
represent a trait-dependent vulnerability of the patients to de
pression, taking place before recurrence of the disease.www.ectjournal.com 3
thorized reproduction of this article is prohibited.
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TABLE 2. Selected Publications Showing the Effect of ECS on Angiogenesis
Author, Year Species/N Used Marker/Technique Summary of Findings
Hellsten et al, 2004 Rats BrdU Endothelial cell and neural precursor proliferation
in the dentate gyrus occurred in concert.N=23
(6 control; 17 ECS)
Hellsten et al, 2005 Rats Total number of endothelial cells
and vessel length estimated
using design based stereological
analysis methods. Endothelial cell
proliferation was assessed
using BrdU
Increase in endothelial cell proliferation
leading to a 30% increase in the total number
of endothelial cells in the ML of the DG
with or without preoxygenation precluding
hypoxia was seen. The increase in cell number
resulted in a 16% increase in vessel length.
N=12
(6 sham; 6 ECS)
Newton et al, 2006 Rats A combination of vascular density
quantification, angiogenic gene
expression analysis, and
immunohistochemistry
A 6% increase in vascular density in the
dentate gyrus. Another hippocampal region,
the stratum lacunosum moleculare exhibited
a robust 20%–30% increase in vascular density.
N=28
(14 sham; 14 ECS)
Jansson et al, 2006 Rats BrdU and the endothelial cell marker
rat endothelial cell antigen-1
A correlating pattern of increases in neuronal
activation and increased endothelial cell
proliferation in different hypothalamic
areas was found.
N=38
(14 control; 24 ECS)
Ekstrand et al, 2008 Rats BrdU Despite common factors regulating neurogenesis
and angiogenesis, ECS-induced proliferation
of neuronal precursors can take place even
if the angiogenic response is blunted
by corticosterone.
N=22
Warner-Schmidt
et al, 2008
Rats BrdU; a single 10-Gy IRR
dose or repeated 5-Gy dose
Disruption of neurogenesis in rat hippocampus
produced by low doses of irradiation was
reversed by ECS. Vascular endothelial growth
factor (VEGF) was an essential mediator
of this effect.
N=8
(4 control; 4 IRR)
DG, dentate gyrus; IRR, (low dose) irradiation; ML, molecular layer.
Bouckaert et al Journal of ECT • Volume 00, Number 00, Month 2014Tendolkar et al investigated the effect of bitemporal EC
on hippocampus and amygdala volume in 15 antidepressan
free patients with treatment-refractory depression. Analysis o
normalized volumetric data before and after ECT revealed a sig
nificant volume increase of both hippocampus and amygdalTABLE 3. Selected Publications Showing the Effect of ECS on G
Author, Year Species/N Used Mark
Wennstrom et al, 2003 Rats BrdU and specific
such as chondro
proteoglycan (N
N=18
(6 control; 12 ECS)
Wennstrom et al, 2004 Rats BrdU
N=12
(6 control; 6 ECS)
Wennstrom et al, 2006 Rats BrdU and analyze
with the glial ceN=47
(24 sham; 23 ECS)
Jansson et al, 2009 Rats The expression of
for activated mi
for activated ast
analyzed in 3 di
immunofluoresc
N=20
Kaae et al, 2012 Rats Optical fractionato
varying samplin
used to count ne
N=32
(16 sham; 16 ECS)
4 www.ectjournal.com
Copyright © Lippincott Williams & Wilkins. Unauwithout evidence for a change in global brain volume. Ther
was no correlation with the clinical response.
Dukart et al97 carried out a study with drug-responsiv
patients receiving no ECT (n = 24) and drug-resistant patien
receiving right unilateral ECT (n = 10). The effect of ECT oliogenesis
er/Technique Summary of Findings
cell type markers
itin sulfate
G2)
ECS can induce a strong proliferation
of glial progenitor cells in the adult rat
hippocampus.
ECS significantly increased the number of
NG2+ glial cells (also considered as a
neurogenesis precursors) and mature
oligodendrocytes in the adult rat amygdala.
d for colabeling
ll markers
ECS is able to counteract the
glucocorticoid-induced inhibition
of NG2+ cell proliferation and
restore the gliogenesis rate to
baseline levels.
2 different markers
croglia and 1 marker
rocytes (nestin) were
fferent double
ence stainings
ECS induced transient glial cell activation in
prefrontal cortex, hippocampus, amygdala,
hypothalamus, piriform cortex, and
entorhinal cortex regardless of the
stimulus parameter used.
r with
g fractions was
urons or glial cells
ECS increased the number of glial cells
in hilus significantly.
© 2014 Lippincott Williams & Wilkins
thorized reproduction of this article is prohibited.
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TABLE 4. Electroconvulsive Therapy Human Studies and BDNF
Author, Year N
Sex
(F/M)
Mean
Age
Electrode
Position Medication Results
Bocchio-Chiavetto
et al, 2006
23 16/7 53 BL Anti-D Increase of serum BDNF 1 day and 1 month after
last ECT and in a patient subgroup that
had low baseline BDNF levels.
No correlation between BDNF levels and
depressive symptoms (MADRS).
Marano et al, 2007 15 4/11 50 BF/BT Anti-D Increase of plasma BDNF after the fourth ECT
compared to 1 day before ECT.
Change accompanied by significant decrease in
HAM-D score in 13 subjects.
Okamoto et al, 2008 18 9/9 60.6 BL Anti-D Responders showed increase of serum BDNF
5 weeks after first ECT; nonresponders
(n = 6) did not show increased serum BDNF.
Fernandes et al, 2009 15 10/5 52.7 UL Anti-D; anti-P No changes in serum BDNF between baseline
and day of last ECT.
Gronli et al, 2009 10 NA NA UL Anti-D and
or PT
No changes in serum BDNF between baseline,
after the fourth ECT and eighth ECT.
Piccinni et al, 2009 18 9/9 44.9 BL Anti-D; mood
stabilizers
Increase of plasma BDNF 1 week after last ECT
although only in remitted patients with
increased baseline plasma BDNF; parallel
with clinical response.
Hu et al, 2010 28 23/5 41 BF No anti-D Increase of serum BDNF 2 weeks after
completion of ECT compared to baseline.
Increasing rate of serum BDNF correlating with
decreasing rate of HAM-D.
Gedge et al, 2012 11 7/4 46.5 NS Anti-D; benzo;
anti-P
No difference between pretreatment and
posttreatment serum BDNF levels
(7 days before ECT and 7 days after
treatment completion)
Lin et al, 2013 55 44/11 46.5 BF No
psychotropics
No change of plasma BDNF after last ECT and
no correlation with clinical response
Stelzhammer et al,
2013
12 NS 52. 6 UL but
only 2.5
above ST
Anti-D after
first 2 weeks
Decreased serum BDNF levels after acute ECT.
Patients received only ECT treatments over the
first 2 weeks and a combination of ECT and
antidepressant drugs (AD) over the subsequent
2 weeks. Sera were taken 6 hours after ECT.
Haghighi et al, 2013 40 30/10 31.4 BF Citalopram Comparison of group taking citalopram
only and group taking citalopram and additional
12 ECT sessions.
101% increase of plasma BDNF in citalopram
and ECT group, without relation to decrease in
symptom severity.
Anti-D, antidepressants; anti-P, antipsychotics; benzo, benzodiazepines; BF, bifrontal electrode position; BL, bilateral electrode position; HAM-D,
Hamilton Depression Rating Scale; MADRS, Montgomery-Asberg Depression Rating Scale; N, number of subjects; NS, not specified; ST, seizure
threshold; UL, unilateral electrode position.
Journal of ECT • Volume 00, Number 00, Month 2014 Brain Enabling Effects of ECTbrain anatomy was monitored using voxel-based morphometr
on magnetic resonance brain data at entry and at 3 month
Electroconvulsive therapy was correlated with regional in
creases in local gray matter volume (GMV) only in the righ
hemisphere, and significantly higher GMV was demonstrate
in the subgenual cortex and hippocampal complex (hippocam
pus, amygdala, and anterior temporal pole), paralleled by pre
frontal cortex GMV decreases in the ECT group compare
with patients with no ECT. A significantly higher GMV in hip
pocampal complex was also seen compared to the contro
group (n = 21). Changes in GMV in the subgenual cortex an
the hippocampal complex were also significant predictors o
improved depression scores after ECT.© 2014 Lippincott Williams & Wilkins
Copyright © Lippincott Williams & Wilkins. UnauMagnetic Resonance Spectroscopic Imaging
Magnetic resonance spectroscopic imaging studies are con
siderably more sensitive than structural imaging in assessin
pathologic changes in the brain even if morphologic change
are absent.98 It allows a view of brain chemical activity
N-acetylaspartate (NAA), an amino acid exclusively locate
in neurons, has been demonstrated to be a sensitive marker o
neural function. In a sample of 17 patients treated with ECT
Ende et al99 found no immediate changes in the NAA signa
corroborating that ECT does not lead to immediate neurona
loss or dysfunction. A significant increase in signals from cho
line (Ch)-containing compounds in these 17 patients was see
during and immediately after a complete course of ECT. Patientswww.ectjournal.com 5
thorized reproduction of this article is prohibited.
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Bouckaert et al Journal of ECT • Volume 00, Number 00, Month 2014pre-ECT Ch signals were low compared with those of health
subjects. An increased Ch signal might reflect an ECT-induce
increased membrane turnover, possibly owing to mossy fibe
sprouting. These findings have been replicated in both hu
man98,100 and animal studies.101–103h
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:DISCUSSION
Most results presented in the animal studies are in line wit
the neurogenesis hypothesis and support the idea of an impo
tant influence of ECS on neuroplasticity. However, the anima
data are based on unchallenged animals or they apply to exper
mental models useful only in studies of stress.35 It is therefor
difficult to ascertain if alterations in hippocampal neurogenes
are due to stress, anxiety, depression, or a combination. Onl
the nonhuman primates studies used an untreated control grou
(next to a treatment and sham group) to show increased cell pro
liferation after ECS.
Similar to studies with antidepressant treatment, animal stud
ies have shown an increased number of neurons in the hippocampu
after ECS, and inhibitory effects of stress on neuroplasticity hav
been found to be diminished by ECS.50 Hippocampal neurogene
sis seems to be necessary for antidepressive effects,104,105 althoug
this has been and still is a matter of debate.29,106 A decrease i
neurogenesis does not seem to be causative for depression.30
Electroconvulsive stimulation is clearly a more potent stim
ulator of neuroplasticity than antidepressants55 and increase
cell proliferation by 2.5- to 4-fold compared with approximatel
1.5-fold for antidepressants.107 Another example of the mor
potent mechanism of ECS is shown by the increase in prolifera
tion of neural stem cells at an early mitotic phase followe
by increases of neural progenitor cells at a later phase in th
subgranular zone of the hippocampus.65 Chronic administra
tion of fluoxetine only increases proliferation of neural progen
tor cells in the hippocampus without affecting neural stem ce
proliferation.108 Although limited by data in mice that did no
show a depressivelike phenotype before ECS, Weber et al5
(2013) provided the definitive link between ECS-induced type-
cell proliferation and the generation of newborn neurons. Norma
izing or enhancing hippocampal neurogenesis during depressio
could restore the hippocampus as central regulator of HPA system
activity.27,109
In animal models, it has been suggested that increase
expression of BDNF is necessary but not sufficient for the in
duction of mossy fiber sprouting.7 However, ECS-induce
mossy fiber sprouting and BDNF expression are attenuated b
ketamine pretreatment,110 whereas cell proliferation seems t
be still present.111
The human data are based on relatively few patient group
The inconsistencies in the available literature on the topi
of ECT and BDNF reflects heterogeneity among the include
patients in diagnosis and clinical features (polarity of illnes
presence of psychotic features, and history of treatment resis
tance), and a heterogeneity in the used methodology (electrod
placement, concomitant psychotropic drug treatment), measure
ment in peripheral blood (serum or plasma), timing of bloo
sampling, technique to assay BDNF levels, use of differen
enzyme-linked immunosorbent assay kit).79,112,113 Given th
conflicting results, future studies on serum levels of BDN
should also correct for the time of blood withdrawal, storag
time and temperature, urbanicity, age, sex, smoking status, an
food and alcohol intake.114 Whereas ECT may increase BDN
levels, it remains unclear as to when this increase occurs. Th
time point at which posttreatment BDNF levels are measure
has not been consistent throughout the studies (during treatmen6 www.ectjournal.com
Copyright © Lippincott Williams & Wilkins. Unauthe day after the last ECT, 1 week after the end of ECT, o
1 month after the end of ECT). For the time being, it is too earl
to conclude that the effect of ECT on BDNF is central to the e
ficacy of ECT in the treatment of major depressive disorder. It
also not clear whether BDNF and other growth factors ar
markers or rather mechanisms of illness improvement.78
Three recent longitudinal MRI studies have demonstrate
increases in hippocampal volume after ECT,94–97 with one re
porting a return to baseline at a later time point.95 There is som
evidence suggesting that edema is unlikely to be the primar
cause of these volume changes, opening up the possibility of
neuroplasticity-based hypothesis.93,94
The hippocampal volume increase seen in these longitud
nal MRI studies after ECT94–97 could be related to a restoratio
of cell number or neuropil, as antidepressants reverse dendriti
shrinkage and improve cell survival, activating the antiapoptoti
protein Bcl-2 and BDNF expression.115,116 Interestingly, EC
up-regulates the antiapoptotic gene BCL2 in the dentate re
gions where neurogenesis occurs.117 However, as the volum
increase was seen 1 week after treatment, it may well reflec
short-term structural plasticity mediated by increases in progenito
proliferation.118
Nordgren et al119 hypothesized that ECT causes transien
down-regulation of key molecules needed to stabilize synapti
structures and to prevent calcium influx, and a simultaneou
increase in neurotrophic factors, thus providing a short tim
window of increased structural synaptic plasticity. The
findings indicate that the window of plasticity with increase
neuromodulation is followed by a later phase during which th
synaptic network is stabilized in a new, slightly altered configura
tion. Both effect and adverse effects of ECT may thus be cause
by structural synaptic rearrangements, as already suggested
decades ago.120
Future research should develop radiopharmaceutical mo
ecules tagged with positron-emitting isotopes enabling in viv
neuroimaging of neuroplasticity121 to study cell proliferation
cell connectivity, and functional integration into brain circui
before, during, and after ECT.
We need to continue investigating whether seizure-induce
structural changes are crucial for the therapeutic efficacy o
ECT, have impact on cognitive changes, or should rather be con
sidered as an epiphenomenon.
CONCLUSION
It remains unclear whether structural changes might explai
the therapeutic efficacy and/or be related to the (transient) learn
ing and memory impairment after ECT. Methods to assess i
vivo brain plasticity of patients treated with ECT and its corre
lations with treatment outcome will be of particular importanc
for future longitudinal studies to give support to the currentl
available correlational data.
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